Local PPO · observed 2026 → 2026 · 39 months of CPSC history · 20 active CY 2025 plans.
| Plan | Category | Premium | MOOP | ★ | Counties | Enrollment |
|---|---|---|---|---|---|---|
| Aetna Medicare Freedom (PPO) H2293/016 | MA-PD | $0 | $5,900 | 4.0 | 16 | 27,116 |
| Aetna Medicare Freedom Plus (PPO) H2293/031 | MA-PD | $0 | $6,900 | 4.0 | 122 | 26,921 |
| Aetna Medicare Dual Choice (PPO D-SNP) H2293/021 · Dual-Eligible | SNP | $18 | $9,350 | 4.0 | 109 | 15,006 |
| Aetna Medicare Value Plus (PPO) H2293/001 | MA-PD | $40 | $9,350 | 4.0 | 109 | 11,540 |
| Aetna Medicare Signature (PPO) H2293/028 | MA-PD | $0 | $6,900 | 4.0 | 2 | 7,427 |
| Aetna Medicare Giveback Choice Plus (PPO) H2293/010 | MA-PD | $0 | $9,350 | 4.0 | 18 | 6,769 |
| Aetna Medicare Freedom Preferred (PPO) H2293/014 | MA-PD | $0 | $6,350 | 4.0 | 33 | 6,657 |
| Aetna Medicare Dual Signature Choice (PPO D-SNP) H2293/002 · Dual-Eligible | SNP | $31 | $9,350 | 4.0 | 14 | 5,889 |
| Aetna Medicare Freedom (PPO) H2293/019 | MA-PD | $0 | $6,350 | 4.0 | 8 | 5,137 |
| Aetna Medicare Dual Signature Choice (PPO D-SNP) H2293/005 · Dual-Eligible | SNP | $24 | $9,350 | 4.0 | 39 | 4,261 |
| Aetna Medicare Freedom (PPO) H2293/017 | MA-PD | $0 | $6,750 | 4.0 | 5 | 3,590 |
| Aetna Medicare Signature (PPO) H2293/029 | MA-PD | $0 | $6,900 | 4.0 | 23 | 2,752 |
| Aetna Medicare Value Plus (PPO) H2293/011 | MA-PD | $9 | $9,350 | 4.0 | 2 | 2,748 |
| Aetna Medicare Dual Signature Select (PPO D-SNP) H2293/003 · Dual-Eligible | SNP | $31 | $9,350 | 4.0 | 14 | 2,730 |
| Aetna Medicare Value Plus Signature (PPO) H2293/023 | MA-PD | $16 | $9,350 | 4.0 | 36 | 2,229 |
| Aetna Medicare Freedom Core (PPO) H2293/026 | MA-PD | $0 | $6,750 | 4.0 | 3 | 1,919 |
| Aetna Medicare Value Plus (PPO) H2293/033 | MA-PD | $16 | $9,350 | 4.0 | 35 | 1,042 |
| Aetna Medicare Dual Signature Select (PPO D-SNP) H2293/004 · Dual-Eligible | SNP | $21 | $9,350 | 4.0 | 39 | 1,023 |
| Aetna Medicare Eagle Plus (PPO) H2293/009 | MA | — | $8,900 | 4.0 | 158 | 840 |
| Aetna Medicare Freedom Core (PPO) H2293/025 | MA-PD | $27 | $6,750 | 4.0 | 8 | 628 |
| ID | Measure | ★ |
|---|---|---|
| C01 | Breast Cancer Screening | 4.0 |
| C02 | Colorectal Cancer Screening | 4.0 |
| C03 | Annual Flu Vaccine | 3.0 |
| C04 | Monitoring Physical Activity | — |
| C05 | Special Needs Plan (SNP) Care Management | 3.0 |
| C06 | Care for Older Adults � Medication Review | 5.0 |
| C07 | Care for Older Adults � Pain Assessment | 5.0 |
| C08 | Osteoporosis Management in Women who had a Fracture | 4.0 |
| C09 | Diabetes Care � Eye Exam | 3.0 |
| C10 | Diabetes Care � Blood Sugar Controlled | 5.0 |
| C11 | Controlling High Blood Pressure | 3.0 |
| C12 | Reducing the Risk of Falling | — |
| C13 | Improving Bladder Control | — |
| C14 | Medication Reconciliation Post-Discharge | 5.0 |
| C15 | Plan All-Cause Readmissions | 3.0 |
| C16 | Statin Therapy for Patients with Cardiovascular Disease | 3.0 |
| C17 | Transitions of Care | 3.0 |
| C18 | Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions | 4.0 |
| C19 | Getting Needed Care | 3.0 |
| C20 | Getting Appointments and Care Quickly | 4.0 |
| C21 | Customer Service | 3.0 |
| C22 | Rating of Health Care Quality | 4.0 |
| C23 | Rating of Health Plan | 4.0 |
| C24 | Care Coordination | 3.0 |
| C25 | Complaints about the Health Plan | 4.0 |
| C26 | Members Choosing to Leave the Plan | 4.0 |
| C27 | Health Plan Quality Improvement | — |
| C28 | Plan Makes Timely Decisions about Appeals | 4.0 |
| C29 | Reviewing Appeals Decisions | 4.0 |
| C30 | Call Center � Foreign Language Interpreter and TTY Availability | 5.0 |
| D01 | Call Center � Foreign Language Interpreter and TTY Availability | 4.0 |
| D02 | Complaints about the Drug Plan | 4.0 |
| D03 | Members Choosing to Leave the Plan | 4.0 |
| D04 | Drug Plan Quality Improvement | — |
| D05 | Rating of Drug Plan | 4.0 |
| D06 | Getting Needed Prescription Drugs | 4.0 |
| D07 | MPF Price Accuracy | 4.0 |
| D08 | Medication Adherence for Diabetes Medications | 2.0 |
| D09 | Medication Adherence for Hypertension (RAS antagonists) | 4.0 |
| D10 | Medication Adherence for Cholesterol (Statins) | 4.0 |
| D11 | MTM Program Completion Rate for CMR | 4.0 |
| D12 | Statin Use in Persons with Diabetes (SUPD) | 2.0 |
No incoming transitions for this contract.